PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BGB-45035 tested for eczema and itchy skin condition
Disease control CompletedThis study tested a new drug called BGB-45035 for the first time in humans. It looked at safety in healthy volunteers and then in people with autoimmune skin diseases like atopic dermatitis (eczema) and prurigo nodularis (a condition causing intensely itchy bumps). The goal was t…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for eczema sufferers with painful itchy nodules?
Disease control CompletedThis study tested the drug upadacitinib in people with moderate to severe atopic dermatitis (eczema) who also have prurigo nodularis, a condition causing intense itching and hard bumps. The goal was to see if the drug reduces itching and improves skin. The study was observational…
Matched conditions: PRURIGO NODULARIS
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New shot could tame uncontrollable itch of prurigo nodularis
Disease control CompletedThis study tested the drug dupilumab in 151 adults with prurigo nodularis, a condition causing intense itching and raised skin bumps. Participants had severe itch that creams could not control. They received either dupilumab injections or a placebo for 24 weeks. The main goal was…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:24 UTC
-
New hope for chronic itch: dupilumab tackles prurigo nodularis
Disease control CompletedThis study tested the drug dupilumab in 160 adults with prurigo nodularis, a skin condition causing intense itching and bumps. Participants received either dupilumab injections or a placebo for up to 24 weeks. The main goal was to see if dupilumab could reduce itch by at least 4 …
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 17:54 UTC
-
New injection shows promise for relieving intense itching
Symptom relief CompletedThis Phase 3 trial tests whether Stapokibart injection can reduce severe itching and skin bumps in adults with prurigo nodularis. About 200 participants will receive either the drug or a placebo for 24 weeks. The main goal is to see if itching improves by at least 4 points on a 0…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug KPL-716 aims to stop the itch of prurigo nodularis
Symptom relief CompletedThis phase 2 trial tested an investigational drug called KPL-716 (vixarelimab) in 240 adults with prurigo nodularis, a skin condition causing intense itching and hard nodules. The study compared the drug to a placebo to see if it could reduce itch severity over several weeks. The…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Itch-Busting cream shows promise for painful skin bumps
Symptom relief CompletedThis Phase 3 trial tested a cream called ruxolitinib (also known as Opzelura) in 190 adults with prurigo nodularis, a skin condition causing intense itching and hard bumps. Participants applied the cream twice daily for 12 weeks. The main goal was to see if it could reduce itch b…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Eye movement therapy shows promise for itchy skin conditions
Symptom relief CompletedThis study tested a behavioral therapy called EMD-U in 96 adults with atopic dermatitis or prurigo nodularis who had a strong urge to scratch. The therapy involves focusing on the itchy spot while moving the eyes, repeated until the urge fades. Researchers compared EMD-U plus usu…
Matched conditions: PRURIGO NODULARIS
Phase: NA • Sponsor: Tamar Nijsten • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New cream offers hope for unbearable itch
Symptom relief CompletedThis Phase 3 trial tested a cream containing ruxolitinib in 204 adults with prurigo nodularis, a skin condition causing intense itching and hard bumps. Participants applied the cream twice daily for 12 weeks. The main goal was to see if it reduced itch by at least 4 points on a 0…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC